Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report

Atypical carcinoid tumours are relatively rare among lung cancers. Surgery is regarded as standard treatment for localized cases, but there is little established evidence on treatment strategies for advanced cases. Moreover, the efficacy of immune checkpoint inhibitors for advanced carcinoid tumours...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yoshihiro, Ijichi, Kayo, Koike, Ai, Nakamura, Satoshi, Takahata, Yuriko, Okamatsu, Yuki, Fujita, Akitaka, Kawakami, Satoru, Harada, Taishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024153/
https://www.ncbi.nlm.nih.gov/pubmed/35475138
http://dx.doi.org/10.1002/rcr2.951
Descripción
Sumario:Atypical carcinoid tumours are relatively rare among lung cancers. Surgery is regarded as standard treatment for localized cases, but there is little established evidence on treatment strategies for advanced cases. Moreover, the efficacy of immune checkpoint inhibitors for advanced carcinoid tumours is unclear. Here, we report a case of a patient with an atypical carcinoid tumour in whom successful disease control was achieved with the use of combined cytotoxic chemotherapy and immunotherapy.

Ejemplares similares